Dashboard
Manage Tickers

VNDA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-maintains-overweight-on-vanda-pharma-raises-price-target-to-13
Cantor Fitzgerald Maintains Overweight on ...
08/01/2024 16:57:03

Cantor Fitzgerald analyst Charles Duncan maintains Vanda Pharma (NASDAQ:VNDA) with a Overweight and raises the price target ...

vanda-pharmaceuticals-reinstates-guidance-sees-fy24-total-revenues-180m-210m
Vanda Pharmaceuticals Reinstates Guidance;...
07/31/2024 20:52:28

vanda-pharma-q2-2024-gaap-eps-008-beats-021-estimate-sales-50474m-beat-47860m-estimate
Vanda Pharma Q2 2024 GAAP EPS $(0.08) Beat...
07/31/2024 20:28:46

Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.21) ...

cantor-fitzgerald-initiates-coverage-on-vanda-pharma-with-overweight-rating-announces-price-target-of-11
Cantor Fitzgerald Initiates Coverage On Va...
07/11/2024 11:27:49

Cantor Fitzgerald analyst Charles Duncan initiates coverage on Vanda Pharma (NASDAQ:VNDA) with a Overweight rating and annou...

Core News & Articles
US District Court For The District Of Dela...
07/01/2024 12:05:49

whats-going-on-with-vanda-pharmaceuticals-shares-today
What's Going On With Vanda Pharmaceuticals...
06/27/2024 16:10:59

Vanda Pharmaceuticals shares decline as Future Pak withdraws acquisition offer following Vanda's rejection and lack of resp...

future-pak-late-wednesday-announced-the-withdrawal-of-its-proposal-to-purchase-vanda-pharmaceuticals-inc
Future Pak Late Wednesday Announced The Wi...
06/27/2024 13:02:17

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

why-vuzix-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Vuzix Shares Are Trading Higher By Aro...
06/20/2024 12:22:52

vanda-pharmaceuticals-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Vanda Pharmaceuticals And Other Big Stocks...
06/20/2024 09:29:09

reported-wednesday-vanda-pharmaceuticals-rejects-unsolicited-takeover-bids-citing-undervaluation
Reported Wednesday, Vanda Pharmaceuticals ...
06/20/2024 05:49:34

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the Company's Board of Directors (the "Board"...

tesla-nvidia-john-wiley--sons-and-other-big-stocks-moving-higher-on-thursday
Tesla, Nvidia, John Wiley & Sons And Other...
06/13/2024 14:17:19

vanda-pharmaceuticals-receives-revised-unsolicited-acquisition-proposal-from-future-pak-for-850-900-per-share-in-cash-plus-contingent-value-rights-no-shareholder-action-required-at-this-time
Vanda Pharmaceuticals Receives Revised Uns...
06/13/2024 14:03:49

future-pak-increases-cash-portion-of-its-offer-for-vanda-pharmaceuticals-by-075-125-to-850-900-per-share
Future Pak Increases Cash Portion Of Its O...
06/13/2024 12:18:38

https://www.businesswire.com/news/home/20240613906873/en/https://www.businesswire.com/news/home/20240613906873/en/

sp-500-edges-lower-j-m-smucker-shares-surge-following-earnings-beat
S&P 500 Edges Lower; J. M. Smucker Shares ...
06/06/2024 18:45:57

why-g-iii-apparel-shares-are-trading-lower-by-13-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why G-III Apparel Shares Are Trading Lower...
06/06/2024 17:39:18

crude-oil-jumps-2-lululemon-posts-upbeat-earnings
Crude Oil Jumps 2%; Lululemon Posts Upbeat...
06/06/2024 16:22:51

vanda-pharmaceuticals-receives-another-takeover-proposal-considers-466m-deal
Vanda Pharmaceuticals Receives Another Tak...
06/06/2024 16:13:16

Cycle Pharmaceuticals wants to acquire Vanda Pharmaceuticals for $8 per share, or $466 million. Cycle focuses on rare neurologi...

vanda-pharmaceuticals-confirms-unsolicited-non-binding-acquisition-proposal-from-cycle-group-holdings-at-800-per-share-in-cash
Vanda Pharmaceuticals Confirms Unsolicited...
06/06/2024 13:25:08

correction-vanda-pharmaceuticals-shares-are-trading-higher
CORRECTION: Vanda Pharmaceuticals shares a...
06/06/2024 12:15:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION